Insulin Degludec

Welcome to Dwaey, specifically on Insulin Degludec page.
This medicine contains important and useful components, as it consists of
Insulin Degludec is available in the market in concentration.

Generic Name of Insulin Degludec - Learn More

Insulin Degludec

Insulin Degludec Precaution - What You Need to Know

Before starting Insulin Degludec therapy, patients must consult their healthcare provider to ensure its appropriateness for their individual health condition. Key precautions include:

- Hypoglycemia risk: Although Insulin Degludec has a long duration of action and a more stable profile, it can still cause hypoglycemia (low blood sugar), particularly if dosages are not adjusted properly. Patients should be educated on recognizing symptoms of hypoglycemia (shaking, sweating, dizziness, confusion) and how to treat it.
- Allergic reactions: Some patients may experience allergic reactions to Insulin Degludec, including localized redness, swelling, or itching at the injection site. Severe reactions like difficulty breathing or widespread swelling can indicate an anaphylactic reaction and require immediate medical attention.
- Renal and hepatic impairment: In patients with kidney or liver diseases, Insulin Degludec may require dose adjustments due to changes in insulin metabolism. Frequent blood glucose monitoring is necessary to ensure that the insulin dose is appropriate for these patients.
- Fluid retention: Insulin therapy, including Insulin Degludec, can cause fluid retention, leading to edema (swelling), particularly in patients with heart disease. This may be more significant in those using other medications that affect fluid balance, such as certain antihypertensives.
- Insulin resistance: Insulin Degludec is typically well-tolerated, but some patients may develop insulin resistance over time, requiring increased doses for effective blood sugar control.

Insulin Degludec Indication - Uses and Benefits

Insulin Degludec is primarily used to manage diabetes mellitus in both adults and pediatric patients. It is a long-acting insulin analog that helps control blood sugar levels over an extended period. Key indications include:

- Type 1 diabetes mellitus: Insulin Degludec is used as a long-acting insulin in patients with type 1 diabetes, helping to control blood glucose levels throughout the day and night.
- Type 2 diabetes mellitus: It is also used in the treatment of type 2 diabetes, especially when other oral antidiabetic medications or other insulin therapies do not provide sufficient blood sugar control.
- Adjunctive therapy: Insulin Degludec may be used as an adjunct to other forms of insulin or non-insulin medications, especially when achieving adequate control of blood glucose levels with basal insulin alone is not sufficient.

Insulin Degludec Contraindications - Important Warnings

Insulin Degludec should not be used in the following situations to ensure patient safety:

- Hypersensitivity: Patients with a known hypersensitivity or allergy to Insulin Degludec or any of its components should avoid its use.
- Severe hypoglycemia: Insulin Degludec is contraindicated in patients with a history of severe hypoglycemia or those who have episodes of hypoglycemia that are unrecognized, as it may worsen the condition.
- Insulin therapy contraindications: Insulin Degludec should not be used in patients with diabetic ketoacidosis (DKA) unless the condition is being actively managed with appropriate medical interventions.
- Severe liver or kidney disease: Although not an absolute contraindication, patients with severe hepatic or renal impairment may need close monitoring and possible dose adjustments. For those with end-stage renal disease, additional caution is advised.

Insulin Degludec Side Effects - What to Expect

Insulin Degludec is generally well-tolerated, but as with all insulin therapies, it may cause side effects. Common and severe side effects include:

- Common side effects:
- Hypoglycemia: The most common side effect is low blood sugar, which can occur if insulin doses are too high for the food intake or exercise level. Symptoms of hypoglycemia include dizziness, headache, sweating, and confusion.
- Injection site reactions: Patients may experience redness, itching, swelling, or pain at the site of injection.
- Weight gain: Some individuals may experience weight gain due to fluid retention or increased appetite while using insulin.
- Edema: Insulin therapy can cause swelling, especially in the feet, ankles, or legs.

- Severe side effects:
- Severe hypoglycemia: Severe low blood sugar levels can lead to confusion, seizures, unconsciousness, or even death. Patients should know how to recognize and treat hypoglycemia.
- Allergic reactions: Rare, but severe allergic reactions (including anaphylaxis) can occur, with symptoms such as difficulty breathing, swelling of the face or throat, and skin rashes.
- Lipodystrophy: Repeated injections at the same site can lead to changes in the fat tissue, such as lumps or indentations, known as lipodystrophy.
- Hypokalemia (low potassium levels): Insulin therapy can cause low potassium levels, which could lead to muscle weakness, cramps, and arrhythmias.

Insulin Degludec Pregnancy Category ID - Safety Information

3

Insulin Degludec Mode of Action - How It Works

Insulin Degludec is a long-acting insulin analog that mimics the body's natural insulin, helping regulate blood sugar levels. Its mechanism of action involves:

- Long-duration insulin action: Insulin Degludec has a prolonged effect due to its unique formulation, which involves the formation of multi-hexamers at the injection site. These hexamers gradually break down to release the insulin into the bloodstream over a long period, providing stable basal insulin levels with minimal fluctuations.
- Insulin receptor binding: Like other insulins, Insulin Degludec works by binding to insulin receptors on muscle, fat, and liver cells, promoting the uptake of glucose from the bloodstream into cells, thus lowering blood glucose levels.
- Lack of peak: One of the key benefits of Insulin Degludec is that it has no pronounced peak effect, providing a stable and predictable insulin response, which helps reduce the risk of hypoglycemia.

Insulin Degludec Drug Interactions - What to Avoid

Insulin Degludec may interact with several medications, affecting its efficacy or increasing the risk of adverse effects. Key interactions include:

- Oral antidiabetic drugs: When used in combination with other oral antidiabetic agents (such as metformin, sulfonylureas, or DPP-4 inhibitors), Insulin Degludec can enhance blood sugar control. Close monitoring of blood glucose levels is necessary to adjust doses accordingly.
- Corticosteroids: Corticosteroids (e.g., prednisone) can increase blood glucose levels, potentially necessitating adjustments in insulin dosage. Patients on both corticosteroids and insulin should be monitored for hyperglycemia.
- Beta-blockers: Beta-blockers (e.g., propranolol) may mask the symptoms of hypoglycemia, such as trembling, tachycardia, and sweating. Patients on both drugs should monitor their blood glucose closely and educate themselves on the warning signs of hypoglycemia.
- Thiazide diuretics: Thiazide diuretics (e.g., hydrochlorothiazide) can elevate blood glucose levels and reduce insulin effectiveness. Patients may need a higher insulin dose to control their blood sugar when using these medications.
- Alcohol: Alcohol can either increase or decrease blood glucose levels, and its use can complicate blood sugar management. Caution is advised when drinking alcohol, especially in combination with insulin therapy.

Insulin Degludec Adult Dose - Recommended Dosage

The recommended adult dose of Insulin Degludec is individualized based on the patient’s specific needs, blood glucose levels, and other factors. General guidelines include:

- Starting dose: The typical starting dose for Insulin Degludec in adults is 10 units once daily, administered at the same time each day. This dose can be adjusted based on blood glucose monitoring and individual needs.
- Titration: The dose may be adjusted in increments of 2 to 4 units every 3 to 4 days to achieve optimal blood sugar control. Doses higher than 10 units per day are common for individuals with more significant insulin needs.
- Timing: Insulin Degludec is typically administered once daily, regardless of meal times. It can be taken at any time of day, as long as it is consistent each day.

It is essential to monitor blood glucose levels regularly to determine the appropriate dosage for each patient.

Insulin Degludec Child Dose - Dosage for Children

For pediatric patients, Insulin Degludec is used to manage type 1 diabetes. Dosing is individualized based on blood glucose levels and the patient’s insulin requirements:

- Children aged 1 year and older: The typical starting dose is 0.4–0.5 units per kg of body weight per day, administered once daily. The dose can be adjusted based on the patient’s blood glucose control.
- Titration: As with adults, the dose should be adjusted based on regular blood glucose monitoring, increasing or decreasing by 2–4 units as necessary.

It is important for healthcare providers to tailor the dose and monitor the child’s response to insulin therapy closely.

Insulin Degludec Renal Dose - Dosage for Kidney Conditions

In patients with renal impairment, dose adjustments may be necessary due to changes in insulin clearance:

- Mild to moderate renal impairment (CrCl 30-80 mL/min): Insulin Degludec can generally be used at the standard dose, but careful monitoring of blood glucose levels is recommended to adjust the dose as needed.
- Severe renal impairment (CrCl < 30 mL/min): In severe renal impairment, insulin requirements may be reduced. Patients should be closely monitored for hypoglycemia, as insulin clearance may be slower in these individuals. Dose adjustments should be made based on clinical judgment and blood glucose levels.